日日噜夜夜草|一级黄色录像高清版|调教白富美加勒比久久|亚洲欧洲精品婷婷|日韩综合无码色色|日韩精品一区妖精视频|亚洲无码中文字幕hd|99亚洲思思丝袜|手机看片国产精品大胆亚洲|成人无码视频一区二区在线播放

更新于 4月23日

醫(yī)學事務解決方案副經理-北京

2-3.5萬
  • 北京東城區(qū)
  • 1-3年
  • 碩士
  • 全職
  • 招1人

雇員點評標簽

  • 同事很nice
  • 團隊執(zhí)行強
  • 工作環(huán)境好
  • 人際關系好
  • 氛圍活躍
  • 實力大公司

職位描述

藥企
Job Description The Medical Solution Manager is responsible for providing cost effective and innovative solutions to the development and needs of China Medical team in different areas, through engagement with a broader range of internal and external stakeholders, led by Pfizer and China Medical values. The RWE and Study role of Associate Medical Solution Manager, will identify and prioritize RWE gaps, advise innovative RWE projects for different Categories; also as a statistics professional to supervise and provide statistical inputs or consultation to data management and statistical analyses for Pfizer sponsored or cooperative studies (such as NIS or RWS); and will be the facilitator to manage Pfizer sponsored post approval studies (nonregistration purposes) & Research Collaborations through coordination and cooperation with related internal and external stakeholders. All the above duties will be carried out under the guidance of China Medical Excellence/Operations Lead. Real World Evidence: ● Interact with stakeholders to identify and prioritize data gaps and align with local Category teams and global RWE team on appropriate strategies and methods to meet those gaps. ● Identify and evaluate existing external databases and research partners for potential collaboration on RWE projects. ● Accountable as project consultant for coordination of design, planning and delivery of innovative RWE programs. ● Provide RWE-related academic support to internal and external stakeholders by coordinating multiple resources. Statistics: ● From statistical perspectives to advise China Medical team on study design, data management, statistical analysis, interpretation of statistical results, and publications. ● Interact with third parties to supervise and provide statistical inputs to data management and statistical analyses and ensure timeliness and quality of statistical deliverables according to agreement in Pfizer sponsored post approval studies. ● Assistance with the development of statistics-related training courses led by ME&O team. Study Management: ● Establishes the close cross-functional collaboration of all components of a study by working with study team members (including but not limited to Medical Advisors, Study Project Managers, Study Managers, Data Managers, Clinical Programmers, Medical Writers and Project Planners, Safety, Statisticians, Compliance Oversight, Regulatory and Medical QA) both internal and external to Pfizer to ensure studies deliverables. ● Develops working model for study (NIS or Research Collaborations) operation function in China Medical. Overall management on progress, quality, timeline, and budget to ensure all studies conducting smoothly and in accordance with SOP and good quality through leading the team in managing issues and driving for continuous improvement. ● Responsible for overall CRO management and site management to ensure study complied with GCP, SOP, company policy and regulations. ● Responsible for the development and ongoing management of contract and budget internally and externally. ● Creates effective, accurate and timely communication of project progress and issues to local and global leadership. Guides local team in escalation pathways to ensure the issues resolving timely. ● Responsible for PCO, CCR, FCPA, and MQC review to ensure good compliance results. Leads the related trainings for Pfizer colleagues and CRO to ensure compliance. Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates. Medical #LI-PFE

工作地點

北京東城區(qū)五礦廣場-B座

職位發(fā)布者

劉一飛/人事經理

當前在線
立即溝通
公司Logo輝瑞投資有限公司公司標簽
輝瑞公司(Pfizer Inc.)創(chuàng)建于1849年,總部位于美國紐約,是一家以科學為基礎的、創(chuàng)新的、以患者為先的生物制藥公司。輝瑞的使命是“為患者帶來改變其生活的突破創(chuàng)新”。在輝瑞,我們通過科學和全球資源為人們提供治療方案,以延長其生命,顯著改善其生活。在醫(yī)療衛(wèi)生產品的探索、研發(fā)和生產過程中,輝瑞始終致力于奉行嚴格的質量、安全和價值標準。我們在全球的產品組合包括創(chuàng)新藥品和疫苗。每天,輝瑞在發(fā)達和新興市場的員工都在推進人類健康,推動疾病的預防、治療和治愈,以應對挑戰(zhàn)我們這個時代的頑疾。輝瑞還與醫(yī)療衛(wèi)生服務方、政府和社區(qū)合作,支持并促進世界各地的人們能夠獲得更為可靠和可承付的醫(yī)療衛(wèi)生服務。這與輝瑞作為一家全球卓越的創(chuàng)新生物制藥公司的責任是一致的。170余年來,輝瑞一直致力于為所有依賴我們的人帶來改變。輝瑞于1989年進入中國市場。扎根中國30余年,輝瑞已成為在華主要的外資制藥公司之一。2021年是輝瑞新征程的開始。迄今已有170余年歷史的輝瑞正在邁入全新時代,成為一家以科學為基礎的、創(chuàng)新的、以患者為先的生物制藥公司。目前輝瑞在中國業(yè)務覆蓋全國300余個城市,累計投資超過15億美元,并設立了1家先進的生產設施,2個研發(fā)中心(分別位于上海張江高科技園區(qū)和武漢光谷),在華有近7,000名員工分布于業(yè)務、研發(fā)和生產等領域。輝瑞在華上市了五大領域的高品質創(chuàng)新產品,包括腫瘤、疫苗、抗感染、炎癥與免疫、罕見病等多個領域的處方藥和疫苗,強大完善的產品線旨在滿足生命各階段的健康需求。
公司主頁